Myeloperoxidase Aids Heart Attack Risk Prediction With Chest Pain – Study
This article was originally published in The Gray Sheet
Executive Summary
Blood tests for glutathione peroxidase 1 and myeloperoxidase could be used to identify patients at high-risk for adverse coronary events, according to Teri Manolio, MD/PhD, National Heart, Lung & Blood Institute
You may also be interested in...
AACC Speakers Seek Cost-Efficient Cardiac Biomarker Panel
Healthcare cost pressures appear to be shifting the burden of stratifying potential acute coronary syndrome patients to earlier in the hospitalization process
AACC Speakers Seek Cost-Efficient Cardiac Biomarker Panel
Healthcare cost pressures appear to be shifting the burden of stratifying potential acute coronary syndrome patients to earlier in the hospitalization process
Vulnerable Plaque Diagnosis, Treatment: Is Enrollment “Impossible”?
Diagnostic modalities and therapies for vulnerable plaque should be tested simultaneously in one clinical trial to ensure the enrollment size is manageable, according to cardiac researcher James Muller, MD, Massachusetts General Hospital